United Services Automobile Association’s Acorda Therapeutics ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,833
Closed -$5.2M 1487
2017
Q3
$5.2M Sell
1,833
-1,875
-51% -$4.94M 0.02% 753
2017
Q2
$8.77M Buy
3,708
+158
+4% +$313K 0.03% 551
2017
Q1
$8.95M Buy
+3,550
New +$10.2M 0.03% 564
2016
Q2
Sell
-162
Closed -$516K 1301
2016
Q1
$516K Buy
162
+7
+5% +$29.1K ﹤0.01% 1160
2015
Q4
$794K Buy
155
+2
+1% +$8.74K ﹤0.01% 1115
2015
Q3
$485K Sell
153
-7
-4% -$27.1K ﹤0.01% 1176
2015
Q2
$640K Buy
160
+4
+3% +$15.5K ﹤0.01% 1173
2015
Q1
$624K Buy
156
+10
+7% +$45.8K ﹤0.01% 1168
2014
Q4
$717K Buy
146
+51
+54% +$219K ﹤0.01% 1148
2014
Q3
$386K Hold
95
﹤0.01% 1170
2014
Q2
$384K Buy
95
+1
+1% +$4.08K ﹤0.01% 1177
2014
Q1
$428K Hold
94
﹤0.01% 1158
2013
Q4
$330K Hold
94
﹤0.01% 1188
2013
Q3
$387K Hold
94
﹤0.01% 1156
2013
Q2
$373K Buy
+94
New +$387K ﹤0.01% 1143

Other funds holding ACOR

United Services Automobile Association's ACOR Position: Q4 2017 in Review

United Services Automobile Association sold out of Acorda Therapeutics (ACOR) in Q4 2017, closing a stake of 1,833 shares — an estimated $5.2M sold.

United Services Automobile Association first reported a position in ACOR in Q2 2013 and held it in 15 quarters. The position peaked at $8.95M in Q1 2017. 150 funds tracked by Wall St. Rank hold ACOR as of Q4 2017.

  • United Services Automobile Association reported no remaining Acorda Therapeutics position as of Q4 2017 after selling out during the quarter.
  • United Services Automobile Association sold 1,833 Acorda Therapeutics shares in Q4 2017, an estimated $5.2M.
  • United Services Automobile Association first reported a position in Acorda Therapeutics in Q2 2013 and held it in 15 quarters.
  • United Services Automobile Association's Acorda Therapeutics position peaked at $8.95M in Q1 2017.
  • 150 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2017.

Based on United Services Automobile Association's 13F filing for Q4 2017, filed 14 Feb 2018.